{"product_id":"tilray-ansoff-matrix","title":"Tilray Brands Ansoff Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Smarter Expansion Decisions with the Full Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis Tilray Brands Ansoff Matrix Analysis gives you a clear, company-specific view of growth options across market penetration, market development, product development, and diversification. The page already shows a real preview of the actual analysis, so you can review the content and style before buying. Purchase the full version to access the complete ready-to-use report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eM\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003earket Penetration\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpanding retail market share to 14 percent in Canada\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands is using market penetration in Canada by narrowing its portfolio around high-velocity names like Good Supply, aiming to reach 14% retail share. The company has cut nearly 2,500 SKUs and is putting more shelf space behind its strongest items across about 3,000 provincial retail partners. This supports leadership in dried flower and pre-rolls in 2026 and has helped keep the Canadian cannabis segment at positive adjusted EBITDA this fiscal year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeveraging 1,500 craft beer wholesalers across American states\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands is using its 1,500 craft beer wholesalers across U.S. states to push its 8 recently acquired craft beverage brands deeper into retail, raising shelf and cold-box visibility beside national labels. Management is targeting about 70 percent weighted distribution in major U.S. grocery chains, which should lift organic sales within the existing consumer base. Shared logistics routes have already cut distribution costs by 12 percent, helping volume scale faster.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital loyalty programs to retain 85 percent of patients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands uses digital loyalty tools in its Canadian medical cannabis business to keep about 85% of patients active and cut churn. By tracking use data and sending refill reminders, it lowers acquisition cost and supports recurring revenue from its 2 established Canadian facilities. Personalized wellness plans and direct-to-patient shipping deepen trust, and average patient lifetime value is up nearly 18% since early 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAchieving 25 percent German medical market share via pricing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAfter Germany’s 2025 medical-cannabis reforms, Tilray uses its Neumünster EU-GMP site to cut unit costs and pass savings to patients. With 15 medical cultivars and local supply, it can undercut imported rivals while staying quality-compliant. That low-price, high-volume model is aimed at a 25% share of an expanding market, and recent data says it has become the first choice for over 500 new clinics in the last 12 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidating distribution into 3 major Canadian hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTilray Brands’ move to 3 Canadian hubs tightens distribution across the 10 provinces it serves, cutting redundant ship legs and speeding order fulfillment.\u003c\/p\u003e\n\u003cp\u003eThat centralization has lifted inventory forecast accuracy by about 20%, which helps Tilray hold less excess stock and lowers shipping costs.\u003c\/p\u003e\n\u003cp\u003eRetailers get steadier delivery windows and fewer stockouts during peak weekend demand, supporting Tilray’s push toward sustainable net income in Canada.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTilray Sharpens Focus to Boost Share in Canada, U.S. and Germany\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands is driving market penetration by pruning about 2,500 SKUs in Canada to lift Good Supply share toward 14%, while using 1,500 U.S. craft wholesalers to widen shelf reach. In Germany, its Neumünster site supports low-cost medical cannabis volume after 2025 reforms, helping deepen share in existing markets.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eArea\u003c\/th\u003e\n\u003cth\u003eKey data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCanada\u003c\/td\u003e\n\u003ctd\u003e2,500 SKUs cut; 14% target\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S.\u003c\/td\u003e\n\u003ctd\u003e1,500 wholesalers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGermany\u003c\/td\u003e\n\u003ctd\u003eNeumünster site\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\nAnalyzes Tilray Brands’s growth strategy through the four core directions of the Ansoff Matrix\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eEditable Excel File\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\nProvides a clear Tilray Brands Ansoff matrix to quickly identify growth options and reduce strategy uncertainty.\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eM\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003earket Development\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExporting medical products into 15 international legal markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands is pushing market development by exporting medical cannabis from its Portuguese and German cultivation bases into 15 legal markets, including Australia and key EU countries. In fiscal 2025, it expanded registrations for 10 new oil and flower products in Italy and Poland, using its pharma-style quality controls to win regulator trust before adult-use legalization. These exports now make up about 30% of Company Name's international cannabis revenue, showing strong early demand and higher-margin medical sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaunching Montauk Brewing into 12 new US regions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands can use Montauk Brewing’s existing core beers to enter 12 new U.S. regions without starting from zero, a classic market development move. In fiscal 2025, Tilray reported about $821 million in net revenue, with its beverage unit helping fund wider distribution and brand support. Using production in Georgia and Oregon cuts freight and helps place Montauk in metro markets where 21 to 35-year-old craft buyers are growing. The coastal lifestyle message has already tested well in 3 Midwestern pilots, which lowers launch risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDeveloping pharmacy logistics for 20,000 European storefronts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands is extending CC Pharma’s pharmacy logistics into 3 more EU member states, which deepens access to 20,000 European storefronts. The network already handles more than 2,000 pharmaceutical products and about $185 million in annual volume, giving Tilray steadier cash flow than its crop-heavy business. That scale also helps it build supply ties for medical cannabis and generic drugs across Europe.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSecuring adult-use licenses for 3 trial pilot programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTilray Brands uses adult-use trial licenses in Switzerland and parts of Australia to test products in controlled markets and collect direct consumer data before broader legalization. In fiscal 2025, Tilray reported about $821 million in net revenue, so even small pilot wins can matter for future growth. Early results from these 3 pilots point to strong demand for high-terpene profiles from Tilray Brands' Canadian R\u0026amp;D centers, which helps build first-mover brand equity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEntering South American pharmacies with 2 clinical lines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTilray Brands can enter Brazil and Argentina through prescription-only CBD lines, using local distributors to work inside each country’s medical rules and speed pharmacy access. Brazil’s ANVISA and Argentina’s medical-cannabis pathways favor high-quality imported products, which fits Tilray’s GMP-style global standards and helps it win trust where local supply is still thin. As physician awareness rises, the steady month-over-month lift in prescribing doctors points to a long-run clinical share play, not a quick retail push.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTilray’s Fiscal 2025 Growth Gains from Europe and U.S. Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands’ market development in fiscal 2025 leans on regulated export and channel expansion: medical cannabis reached 15 legal markets, and new product registrations in Italy and Poland widened access. The Company Name reported about $821 million in net revenue in fiscal 2025, while CC Pharma’s reach into 20,000 European storefronts and Montauk’s U.S. region expansion give it lower-risk entry paths.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFiscal 2025 metric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet revenue\u003c\/td\u003e\n\u003ctd\u003eabout $821 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegal export markets\u003c\/td\u003e\n\u003ctd\u003e15\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEuropean storefront reach\u003c\/td\u003e\n\u003ctd\u003e20,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eTilray Brands Reference Sources\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Tilray Brands Ansoff Matrix analysis document you’ll receive upon purchase—no surprises, just the full professional version. The preview shown here is pulled directly from the final report, so what you see is exactly what you get. After checkout, the complete document is unlocked for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct Development\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRolling out 10 non-alcoholic beers under SweetWater labels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands is adding 10 non-alcoholic beers under SweetWater labels, using the same craft inputs but a de-alcoholization step at existing facilities. The move fits product development and targets the 15% annual rise in \"sober curious\" demand, giving shoppers low-calorie options for midday socials and athletic events. With FY2025 net revenue of about $821.3 million, Tilray is also giving retailers more variety in the beer aisle.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReleasing 5 hemp-based nutrition products via Nutiva wellness\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands’ Nutiva line adds 5 hemp-based wellness products, including high-protein powders and fiber supplements, aimed at the $40 billion plant-based protein market.\u003c\/p\u003e\n\u003cp\u003eUsing internal organic hemp supply lifts vertical margins versus rivals that buy inputs from third parties.\u003c\/p\u003e\n\u003cp\u003eEarly placement in 500 specialty health stores supports the Product Development move in Ansoff Matrix terms and points to strong sales velocity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCultivating 3 high-CBG strains for clinical focus therapy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands posted about $821 million in fiscal 2025 net revenue, and its product-development move into 3 high-CBG strains fits that scale shift. By using genetic research to sell functional wellness flower for cognitive support and recovery, Tilray can charge about a 20% premium over standard wholesale prices. It also moves the Company closer to a biotech-style cannabis model, not just THC volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntroducing 6 cannabis-infused topicals for medical spa use\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTilray Brands’ 6-product \"Solei\" rollout into Canadian medical spas is a product development move that widens use beyond retail cannabis. The creams and transdermal patches target massage and physiotherapy settings, with proprietary extraction aimed at fast absorption and consistent dosing. By selling through premium spas, Tilray can lift brand position while tapping higher-margin wellness demand, and early user feedback has pointed to strong scent and relief results.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing 4 nitrogen-infused coffee drinks for morning markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTilray Brands has repurposed canning lines to make four nitrogen-charged cold brew lattes, a product move into high-margin morning energy drinks. In FY2025, Tilray reported about $821 million in net revenue, and these coffee drinks now reach 12 major US metro hubs, helping balance demand away from intoxicating products.\u003c\/p\u003e\n\u003cp\u003eThis fits the Product Development play in Ansoff Matrix: new products, same consumer base, faster use of existing plant capacity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTilray Expands Higher-Margin Growth With New Product Formats\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands’ product development in FY2025 centered on new formats for existing channels, led by about $821.3 million in net revenue and rollouts in non-alcoholic beer, hemp wellness, and functional cannabis.\u003c\/p\u003e\n\u003cp\u003eThat includes 10 SweetWater non-alcoholic beers, 5 Nutiva hemp products, and 3 high-CBG strains, all aimed at higher-margin demand without needing new core markets.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMove\u003c\/th\u003e\n\u003cth\u003eFY2025 fact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSweetWater NA beer\u003c\/td\u003e\n\u003ctd\u003e10 SKUs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNutiva hemp\u003c\/td\u003e\n\u003ctd\u003e5 products\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet revenue\u003c\/td\u003e\n\u003ctd\u003e$821.3M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eiversification\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcquisition of a minority stake in 2 wellness resorts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands is broadening beyond cannabis by taking minority stakes in 2 wellness resorts, adding luxury hospitality and medical-spa touchpoints that can showcase products to high-net-worth guests. In FY2025, Tilray reported net revenue of $821.3 million, and this move shifts part of the mix toward higher-margin services while helping reduce exposure to retail price pressure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatenting 40 cannabinoid synthases through bioscience subsidiaries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTilray Brands’ bioscience subsidiaries target rare cannabinoid synthesis for pharmaceutical use, and the company says this work has 40 patents filed or secured. In fiscal 2025, Tilray reported about US$821 million in net revenue, so patents can add a less cyclical layer to a still crop-linked base. Licensing these assets to medical firms can create high-margin income that does not depend on harvests. This is the clearest sign of Tilray shifting from farming to biotech by 2026.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDeploying fintech software to 3,500 global cannabis retailers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands is diversifying beyond cannabis production by using its fintech platform to serve more than 3,500 global retailers with compliant B2B and retail payments. This helps solve the sector’s banking and tax-documentation gaps, while the subscription model can generate steadier, higher-margin revenue than crop-linked sales. By embedding itself in payments, Tilray Brands is moving into the industry’s core financial plumbing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCreating 4 premium gin and bourbon spirit lines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTilray Brands’ diversification move uses Breckenridge Distillery to launch 4 premium gin and bourbon lines, pushing beyond cannabis into non-cannabis spirits. The labels sit in the $50-and-above tier, where demand has stayed stronger than lower-priced booze, and they now ship to over 40 U.S. states. This gives Tilray a steadier consumer packaged goods revenue base to offset cannabis volatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaunching lifestyle apparel with 25 global retail partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTilray Brands is diversifying through lifestyle apparel and accessories, sold with 25 global retail partners in boutique stores. The move targets cannabis-lifestyle buyers who want non-consumable ways to support the brand, while using sustainable materials to fit the product story.\u003c\/p\u003e\n\u003cp\u003eIt also expands reach in countries where cannabis sales remain banned, so the brand can grow awareness without touching regulated plant-touching revenue. Management projects nearly $25 million in secondary revenue by end-2026.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTilray’s FY2025 Mix Shift Cuts Cannabis Dependence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTilray Brands’ diversification in FY2025 leaned into non-cannabis growth, with net revenue of US$821.3 million and a broader mix across spirits, wellness, and biotech. That matters because it lowers reliance on cannabis pricing. The clearest signal is higher-margin, non-plant revenue.\u003c\/p\u003e\n\u003cp\u003eManagement’s push includes 40 patents filed or secured in bioscience and retail reach across 40+ U.S. states for premium spirits. It also targets secondary revenue of nearly US$25 million by end-2026.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFY2025 signal\u003c\/th\u003e\n\u003cth\u003eData\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet revenue\u003c\/td\u003e\n\u003ctd\u003eUS$821.3M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioscience IP\u003c\/td\u003e\n\u003ctd\u003e40 patents\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpirit reach\u003c\/td\u003e\n\u003ctd\u003e40+ states\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Model Business Canvas","offers":[{"title":"Default Title","offer_id":53343393218902,"sku":"tilray-ansoff-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1023\/3954\/3382\/files\/tilray-ansoff-analysis.webp?v=1777711948","url":"https:\/\/modelbusinesscanvas.com\/products\/tilray-ansoff-matrix","provider":"Model Business Canvas","version":"1.0","type":"link"}